START FREE TRIAL
Home Healthcare GE Healthcare

GE Healthcare

$19.00

SKU: GEHC-1 Category:

Description

GE HealthCare’s Sofie Biosciences Acquisition: A New Bet on Precision Medicine!

 

GE Healthcare Technologies Inc. reported solid financial performance in the third quarter of 2026, marked by top-line growth, margin expansion, and operational improvements across its business segments. The company achieved organic revenue growth of 6.2%, with contributions from both product and service revenues increasing by 6.7% and 8.1%, respectively. Orders grew organically by 4%, sustaining momentum from a strong prior-year baseline, while the book-to-bill ratio remained modestly above 1, indicating balanced demand and delivery. Backlog increased 12% year over year to $23.7 billion, reflecting robust future revenue visibility. Margin expansion was notable, with adjusted EBIT margins rising 180 basis points to 16.6%, driven by volume growth, price realization, and ongoing cost control initiatives. These efforts, structured around the company’s Heartbeat management system, yielded operational simplification and productivity enhancements, particularly in Patient Care Solutions where supply chain challenges were addressed. Adjusted earnings per share increased 25.1% to $1.